6-Fluoro-3-(4-piperidyl)-1,2-benzisoxazole hydrochloride, 98.0%, 500g

5-(2-chlorophenyl)-1,3,4-thiadiazol-2-amine, 95.0%, 2.5g

1-Iodo-4-methoxy-2,3-dimethylbenzene, 95.0%, 250mg

Ethanesulfonamide, N-[4-(2,4-difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]-, 98%, 25mg

(2E)-3-(4-chlorophenyl)-1-(2,5-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

2,4-Difluorophenyl isothiocyanate, 99.0%, 5g

Colonne HPLC NUCLEODUR® 100-3 C8 ec, 150 mm, 4,6 mm, 1 pièce(s)

3-Methylimidazo[1,2-a]pyridine, 95%, 250mg

tert-Butyl (R)-2-cyanomorpholine-4-carboxylate, 95%, 100mg

Bouchons ROTILABO®, 18 mm, 25 Pièce(s)

Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1), 99%, 500mg

2-(6-chloro-9H-carbazol-2-yl)propanoic acid, 5g

4H-PYRROLO[2,3-D]THIAZOLE-5-CARBOXYLIC ACID, 97.0%, 100mg